Loss of E-cadherin enhances IGF1-IGF1R pathway activation and sensitizes breast cancers to anti-IGF1R/InsR inhibitors

av Nagle, Alison M., Levine, Kevin M., Tasdemir, Nilgun, Scott, Julie A., Burlbaugh, Kara, Kehm, Justin, Katz, Tiffany A., Boone, David N., Jacobsen, Britta M., Atkinson, Jennifer M., Oesterreich, Steffi, Lee, Adrian V.
I publikationen Clin Cancer Res (2018)